rs2296435
Variant summary
Our verdict is Benign. The variant received -18 ACMG points: 0P and 18B. BP4_ModerateBP6_Very_StrongBA1
The NM_000195.5(HPS1):c.1599-15A>G variant causes a intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.247 in 1,612,042 control chromosomes in the GnomAD database, including 52,105 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★). There are indicators that this mutation may affect the branch point..
Frequency
Consequence
NM_000195.5 intron
Scores
Clinical Significance
Conservation
Publications
- Hermansky-Pudlak syndrome 1Inheritance: AR Classification: DEFINITIVE, STRONG Submitted by: G2P, ClinGen, Labcorp Genetics (formerly Invitae)
- Hermansky-Pudlak syndrome with pulmonary fibrosisInheritance: AR Classification: SUPPORTIVE Submitted by: Orphanet
Genome browser will be placed here
ACMG classification
Our verdict: Benign. The variant received -18 ACMG points.
Variant Effect in Transcripts
ACMG analysis was done for transcript: NM_000195.5. You can select a different transcript below to see updated ACMG assignments.
RefSeq Transcripts
| Selected | Gene | Transcript | Tags | HGVSc | HGVSp | Effect | Exon Rank | Protein | UniProt |
|---|---|---|---|---|---|---|---|---|---|
| HPS1 | NM_000195.5 | MANE Select | c.1599-15A>G | intron | N/A | NP_000186.2 | |||
| HPS1 | NM_001322476.2 | c.1599-15A>G | intron | N/A | NP_001309405.1 | ||||
| HPS1 | NM_001322477.2 | c.1599-15A>G | intron | N/A | NP_001309406.1 |
Ensembl Transcripts
| Selected | Gene | Transcript | Tags | HGVSc | HGVSp | Effect | Exon Rank | Protein | UniProt |
|---|---|---|---|---|---|---|---|---|---|
| HPS1 | ENST00000361490.9 | TSL:1 MANE Select | c.1599-15A>G | intron | N/A | ENSP00000355310.4 | |||
| HPS1 | ENST00000467246.5 | TSL:1 | n.*958-15A>G | intron | N/A | ENSP00000514163.1 | |||
| ENSG00000289758 | ENST00000699159.1 | n.*958-15A>G | intron | N/A | ENSP00000514167.1 |
Frequencies
GnomAD3 genomes AF: 0.224 AC: 33978AN: 152018Hom.: 4242 Cov.: 33 show subpopulations
GnomAD2 exomes AF: 0.271 AC: 67930AN: 250900 AF XY: 0.277 show subpopulations
GnomAD4 exome AF: 0.249 AC: 363790AN: 1459906Hom.: 47860 Cov.: 36 AF XY: 0.254 AC XY: 184776AN XY: 726354 show subpopulations
Age Distribution
GnomAD4 genome AF: 0.223 AC: 33993AN: 152136Hom.: 4245 Cov.: 33 AF XY: 0.228 AC XY: 16935AN XY: 74370 show subpopulations
Age Distribution
ClinVar
Submissions by phenotype
not specified Benign:3
1599-15A>G in intron 16 of HPS1: This variant is not expected to have clinical s ignificance because it has been identified in 24.0% (2061/8600) of European Amer ican chromosomes from a broad population by the NHLBI Exome Sequencing Project ( http://evs.gs.washington.edu/EVS; dbSNP rs2296435).
not provided Benign:3
Hermansky-Pudlak syndrome 1 Benign:2
This variant was observed in the ICSL laboratory as part of a predisposition screen in an ostensibly healthy population. It had not been previously curated by ICSL or reported in the Human Gene Mutation Database (HGMD: prior to June 1st, 2018), and was therefore a candidate for classification through an automated scoring system. Utilizing variant allele frequency, disease prevalence and penetrance estimates, and inheritance mode, an automated score was calculated to assess if this variant is too frequent to cause the disease. Based on the score and internal cut-off values, a variant classified as benign is not then subjected to further curation. The score for this variant resulted in a classification of benign for this disease.
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at